Main Story
-
RAK ICC Launches New Business Centre in Ras Al Khaimah
New initiative creates a dedicated hub for private wealth advisors, family offices and international families in the UAE Ras Al-Khaimah, United Arab Emirates RAK International Corporate Centre (RAK ICC), one of the UAE’s leading international corporate registries for private wealth and cross-border structuring, today announced the launch of its new Business Centre in Ras Al…
Automobile
Tech
Entertainment
-
Dance Without Borders: BYU Ballroom Dance Gives Historic Performances in India
New Delhi | Bengaluru, India The BYU Ballroom Dance Company lit up stages in India for the first time, enchanting over 1,000 audience members with show-stopping performances held on 4 and 6 June 2026 in the nation’s capital and a grand finale in Bengaluru on 9 June. Distinguished guests, including government, interfaith, and community leaders,…
Health
-
Morepen Starts Commercial Supplies Under its Rs. 825 Crore CDMO Mandate; First Rs. 50 Crore Dispatch Already Completed in Q1FY2026-27
Gurugram, Haryana, India Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today issued an update on its recently announced Rs. 825 crore CDMO mandate. The first commercial dispatch, valued at approximately Rs. 50 crore, has already been completed by the company under the program during Q1FY2026-27. This marks the successful transition of the mandate from validation…
-
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
June 30, 2026 20:38 ET | Source: Mesoblast Limited NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has received a Biologics License Application (BLA) filing number from the U.S. Food and Drug Administration (FDA) and has requested a…
-
Basecamp Research brings EDEN’s antibiotic and vaccine design models to Claude Science
Scientists can now design potent antibiotics and rapidly prioritise vaccine targets through Claude Science, thanks to integration with Basecamp Research’s EDEN models. LONDON and CAMBRIDGE, Mass., June 30, 2026 /PRNewswire/ — Basecamp Research today announced that its antibiotic design and vaccine target prediction EDEN models are now available through Claude, including Claude Science, Anthropic’s AI…
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study Sanofi intends to submit the data to support a regulatory application in the…
-
GLOBAL MITOCHONDRIAL HEALTH SUMMIT 2026 POSITIONS MITOCHONDRIAL HEALTH AS THE FOUNDATION OF HEALTHSPAN
Sydney and Kuala Lumpur events unite world-leading experts as Mitochondrial Health gains recognition as a defining force in healthy ageing, and healthspan Researchers and clinicians identify Ubiquinol as a foundational nutrient in the Mitoceuticals category, supporting mitochondrial function throughout life, from preconception to healthy ageing SYDNEY, June 29, 2026 /PRNewswire/ — The inaugural global Mitochondrial Health…
-
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations
Positive CHMP opinion is based on data from the Phase 3 RISE-PD trial, which demonstrated significantly more “Good ON” time with fewer daily doses compared with immediate-release levodopa/carbidopa Hopledo® is already approved and marketed in the United States as CREXONT®, providing established regulatory and commercial experience as the therapy advances toward European approval More than…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
